CCB International

CCB International (Holdings) Limited, established in 1973, is an investment services firm based in Hong Kong and owned by China Construction Bank Corporation. The company operates across a comprehensive value chain that encompasses three primary segments: Pre-IPO, IPO, and Post-IPO services. CCB International offers a wide array of services, including underwriting, financial advisory, corporate mergers and acquisitions, restructuring, and refinancing for listed companies. Additionally, the firm engages in direct investment and asset management, alongside providing securities brokerage, market research, and investment consultancy. Through its subsidiaries, such as CCB International Capital and CCB International Asset Management, the firm delivers diverse investment solutions and services to meet the needs of its clientele.

Alvin Li

Managing Director

Michael Steinberg

Managing Director and CEO

Kaipeng Xia

Managing Director, Direct Investment

68 past transactions

Xinqiang Technology

Series A in 2025
Xinqiang Technology is a digital full-stack solution provider specializing in integrated solutions that combine hardware, software, cloud services, and artificial intelligence (AI) tailored for traditional industries.

Syngenta Group Ventures

Debt Financing in 2024
Syngenta Group is a leading agriculture innovation company with a history spanning over 250 years. Headquartered in Switzerland and owned by a Chinese parent company, it employs around 48,000 individuals across more than 100 countries. The company focuses on transforming agriculture through the development of advanced products and technologies that support the global food chain, ensuring safe and sustainable food production while respecting the environment. Syngenta Group operates through four primary business units: Syngenta Crop Protection, Syngenta Seeds, ADAMA, and Syngenta Group China, each dedicated to providing industry-leading solutions to customers worldwide.

Galaxy Bot

Venture Round in 2024
Galaxy Bot is an innovative robotics company that provides intelligent universal service robotic products.

Sinogene

Series C in 2024
Sinogene is a company that specializes in pet cloning and cell transfer solutions, utilizing somatic cell nuclear transfer technology. It focuses on the cloning and breeding of various types of pets, including working dogs, pet dogs, and purebred breeds, while also offering services for the preservation of somatic cell genes. The company is committed to advancing animal genetic research and believes that improved breeding practices will benefit this field. Sinogene's team comprises scientists, doctors, and veterinary specialists dedicated to providing reliable and effective pet cloning and gene editing services for pet owners.

Hangzhou Times Electric Technology

Series A in 2023
Times Electric is a developer of new energy vehicles and core components.

Thor Innovation

Series A in 2023
Thor Innovation is a high-tech company that specializes in haptic technology, which simulates tactile sensations electronically. The firm develops and manufactures solutions aimed at enhancing user experiences in consumer electronics, automotive applications, and healthcare. By utilizing wide-band haptic technology, Thor Innovation provides integrated solutions that deliver immersive experiences in extended reality and digital interactions through physical feedback. This technology allows consumers to engage with digital environments in a more realistic manner, enhancing the overall interaction experience.

Chilye

Venture Round in 2022
Chilye specializes in high-power electronic components and high-voltage connectors, focusing on the development and production of power distribution units, manual service disconnectors, charging and swapping connectors, and portable charging equipment. The company is dedicated to creating a comprehensive range of high-voltage electrical units specifically designed for alternative energy vehicles. By emphasizing technical research and development, Chilye provides clients with integrated solutions for complete vehicle systems in the electric vehicle sector.

GalaxySpace

Series D in 2022
GalaxySpace is a satellite manufacturer based in Haidian, China, founded in 2016. The company specializes in developing and building a low Earth orbit (LEO) broadband satellite constellation and a 5G communication network. GalaxySpace offers various satellite applications, including monitoring systems for airports, parking, and oil reserves, as well as land assessment services. Their product range includes communication payloads, phased array antennas, power management systems, solar panels, and core platform components. Additionally, the company provides one-stop artificial intelligence satellite launch services, facilitating convenient communication and information access for clients while reducing network costs.

Origin Quantum

Series B in 2022
Origin Quantum is a full-stack quantum computing company based in China, established in 2017. The company specializes in the development and application of quantum computing technologies, including quantum chips, measurement and control systems, and quantum software. It offers a quantum computing cloud service platform that facilitates access to quantum computing resources beyond laboratory settings. Origin Quantum is committed to advancing the engineering and industrialization of quantum computing in China, aiming to accelerate its applications across various sectors, including quantum artificial intelligence.

Shenzhen TargetRx

Series B in 2022
Shenzhen TargetRx, Inc. is a pharmaceutical research and development company based in Shenzhen, China, established in 2014. As a Sino-American joint venture, it focuses on the creation of innovative anti-tumor drugs, specializing in third-generation small molecule targeted therapies for cancer patients. The company is dedicated to addressing challenges such as acquired drug resistance in cancer treatment. Under the leadership of Dr. Yihan Wang, a prominent medical expert with extensive experience in small molecule targeted therapies, Shenzhen TargetRx aims to position itself as a leading platform for targeted drug development. The company engages in the design, screening, evaluation, optimization, and research of original anti-tumor drug candidates, holding independent intellectual property rights to its innovations. With a commitment to improving cancer treatment outcomes, Shenzhen TargetRx strives to transform cancer from a leading cause of mortality into a manageable chronic condition.

Mirxes

Series C in 2022
MiRXES Pte. Ltd., founded in 2014 and based in Singapore, specializes in life science research tools and molecular diagnostic tests for both research and clinical applications. The company has developed a leading microRNA (miRNA) detection assay platform designed to identify cancer at asymptomatic stages. Its product offerings include RT-qPCR assays, assay panels, spike-in RNA kits, and solutions for biomarker discovery. By focusing on early cancer detection, MiRXES provides healthcare professionals with essential diagnostic tools to improve clinical outcomes through timely intervention.

Tianbing Technology

Series B in 2022
Tianbing Technology is an advanced aerospace propulsion system supplier and aerospace vehicle provider. Tianbing Technology independently develops the next-generation ambient temperature green HCP liquid propellant and minimalist aerospace propulsion system. As an upgraded product of traditional chemical propulsion system, it can meet cost-effective aerospace. Advance system supporting needs. The next-generation green HCP aerospace propulsion system, first tested by Tianbing Technology, can be used in the small-vehicle main power and launch vehicle upper-level propulsion system.

Keydom

Post in 2022
Keydom is the provider of smart card industry application solution services.

Moore Threads

Series A in 2021
Moore Threads, founded in 2020 and based in Beijing, China, specializes in developing Graphics Processing Unit (GPU) technology and services. The company focuses on enabling visual computing, artificial intelligence, and high-performance computing applications for a diverse range of sectors, including gaming and the creative industry. By providing advanced GPU technology and services for data centers, edge computing servers, professional workstations, and high-performance PCs, Moore Threads helps clients achieve significant computational power for their processes.

Wego

Series A in 2021
Wego is a manufacturer of producing safe and affordable medical equipment.

Hozon

Series D in 2021
Zhejiang Hozon New Energy Automobile Co., Ltd., founded in 2014 and headquartered in Tongxiang, China, specializes in the design and manufacture of electric vehicles. The company offers models such as the Nezha U, Nezha N01, and Eureka 02, focusing on the integration of hardware and software to enhance user experience. Hozon emphasizes innovative technology research and development, intelligent manufacturing, and multi-channel sales services to produce cost-effective, high-quality intelligent electric vehicles. With research and development centers in both China and the United States, Hozon aims to advance electricity, intelligence, and connectivity in its offerings, ensuring a simple, intuitive, and comfortable travel experience for its users.

SJ Semi

Series C in 2021
SJ Semi is a MEOL foundry focused on front-end wafer manufacturing and quality systems. The company specializes in bumping, Cu pillar, RDL, and testing services for 12" wafers while investing in R&D for fan-out, TSV, interposer, and 3D technologies. With over a decade of experience, SJ Semi aims to support advancements in the semiconductor market.

IASO Biotherapeutics

Series C in 2021
Nanjing IASO Biotherapeutics is a clinical stage biotechnology company established in 2017 and located in Nanjing, China. The company specializes in the discovery, development, and commercialization of innovative therapies aimed at treating cancer. IASO Biotherapeutics is particularly focused on engineered autologous and allogenic T cell therapies, which are designed to enhance the immune system's capability to identify and eliminate cancer cells. Through its research and development efforts, the company aims to provide effective cancer treatments that leverage the body's own immune response.

OrbusNeich Medical

Series B in 2021
OrbusNeich Medical is a global medical device manufacturer based in China, specializing in endovascular interventional instruments. Established in 2001, the company has developed a comprehensive range of vascular solutions that are recognized for their industry-leading standards. As of 2023, OrbusNeich's revenue is predominantly generated from its coronary interventional medical devices, including scoring balloons, non-compliant balloons, and stents, which collectively account for 82.7% of total revenue. Geographically, the company derives the largest share of its revenue from Japan (24.7%), followed by Europe, the Middle East, and Africa (23.6%), with the remainder coming from the Asia-Pacific region and the United States. OrbusNeich continues to focus on innovation and quality in its product offerings to improve patient outcomes in vascular interventions.

Kuaikan Manhua

Series F in 2021
Kuaikan Manhua is an online and mobile platform for original online comic artwork targeting young readers. Founded in 2014, Kuaikan Manhua is a comic-reading platform and community of interest that is popular among users. As of January 2019, the total number of users of the comics app is over 170 million, and the monthly users are over 40 million, and the market share in the comics market is more than half*. Kuaikan World’s vision is to build an ideal ecosystem of cultural-entertainment in the future, as well as bring happiness to the world. Kuaikan aims to help comic creators to create more widely-popular comics with positive, energetic and warm contents to millions of users.

Beijing Health Guard Biotechnology

Private Equity Round in 2021
Beijing Health Guard Biotechnology is a research and development company that develops recombinant protein drugs for the biotech industry. The company also specializes in the research and development of novel biopharmaceuticals featuring a structure-guided design approach. Beijing Health Guard Biotechnology was founded in 2008 and is based in Beijing, China.

SVOLT

Series B in 2021
SVOLT manufacturer of electric batteries. They specialize in the manufacturing of automotive power batteries and energy storage systems. Their market applications include passenger cars, commercial vehicles, energy storage, and light power solutions. Their products include batteries and energy storage batterie. They provide users with energy vehicle charging piles, batteries recycling, and solutions.

Beijing Gene+ Technology

Series C in 2021
Beijing Gene+, also known as Beijing Gene Plus, provides gene testing services for cancer prevention, early detection, as well as providing data for the implementation of precision medicine. The company claims to operate in around 100 hospitals and have served thousands of cancer patients in China.

Geneplus-Beijing Co. Ltd.

Series C in 2021
Geneplus Co.,Ltd. is a market leader in biotechnology and molecular diagnostic distribution. The company is primarily concerned with molecular biological solutions for Applied Life Science and Molecular Diagnostics.

Shanghai Cell Therapy Group

Series D in 2021
Shanghai Cell Therapy Group Co., Ltd., founded in 2013 and headquartered in Shanghai, China, specializes in the field of cell therapy technology. The company offers a range of services, including technical consulting, technology transfer, and investment in the healthcare sector. It operates a cellular diagnosis center that integrates cellular research and treatment services, focusing on tumor immune cell therapy treatments. Additionally, the company provides cellular cold storage, develops cellular pharmaceuticals, and conducts antibody research, thereby enabling patients to undergo genetic testing and supplying valuable research data to cancer facilities.

Didi Woya

Series A in 2021
Didi Woya is a pioneering startup focused on creating autonomous vehicles for rideshares. Their goal is to revolutionize transportation services by providing efficient, affordable, and comfortable rides with rapid response times and budget-friendly fares. Utilizing cutting-edge technologies such as machine learning, the Internet of Things, and comprehensive 360-degree monitoring, DiDi Woya is dedicated to developing and commercializing innovative solutions in the field.

Youyun

Debt Financing in 2020
Youyun is the designer of a full-stack operation and maintenance service platform aimed at increasing company efficiency. They specialize in creating a variety of cloud-based business software solutions that increase the effectiveness of enterprise management and maintenance while enabling quick and efficient digital transportation for a range of sectors.

Biostar Technologies

Series E in 2020
Beijing Biostar Technologies, Ltd. is a biotechnology company based in Beijing, China, founded in 2002. The company specializes in the development of anti-tumor chemotherapy biopharmaceuticals, focusing on the innovation and formulation of small molecule chemical drugs for cancer treatment. Led by a team of Chinese scientists, Biostar engages in biomedical development and technology transfer, offering technical service consulting as part of its operations. The company is recognized for its pioneering work in creating new anti-cancer drugs, including the development of epothilone, and its technologies are considered to be at an internationally advanced level.

UtmoLight

Seed Round in 2020
UtmoLight is engaged in the research, development, and manufacturing of perovskite-based photovoltaic and optoelectronic products. The company focuses on creating advanced perovskite solar cells and modules, along with perovskite quantum dots and associated precursor materials. It specializes in synthesizing full visible spectrum perovskite quantum dots and developing enhanced filter films utilizing these quantum dots. By leveraging its expertise in perovskite technology, UtmoLight aims to provide high-quality photoelectric products for clients in the photovoltaic and optoelectronic sectors.

Hinova Pharma

Series C in 2020
Hinova Pharma is an innovative drug research and development manufacturer that provides users with compound HC-1119 androgen receptor (AR) antagonism by using drug discovery systems such as medicinal chemistry, biological screening, process research, quality research, clinical reporting, and clinical research. Drugs, HC-1102 androgen receptor inhibitors and other products, for the treatment of advanced prostate cancer and breast cancer.

Sinovent

Series C in 2020
Sinovent Inc. is a biopharmaceutical company established in 2016, with its headquarters in Suzhou, China, and additional offices in Beijing and Boston. The company focuses on developing innovative treatment methods through its advanced biotechnology platform and extensive management experience. Sinovent aims to address global healthcare challenges by combining expertise in science, management, and finance. Currently, it has 12 products in development, primarily targeting oncology, autoimmune diseases, and infectious diseases.

Thousand Oaks Biopharmaceuticals

Series B in 2020
Thousand Oaks Biopharmaceuticals, Inc., established in 2017 and located in Haimen, China, specializes in contract development and manufacturing services tailored for the biotechnology sector. The company focuses on developing biopharmaceutical technologies aimed at producing protein and vaccine compounds. It offers integrated control solutions that enhance production processes by optimizing protein expression and reducing production scale. This enables biopharmaceutical companies to access personalized, chemically-defined cell culture media, formula production, technical support, and ancillary services. By providing these comprehensive services, Thousand Oaks Biopharmaceuticals aims to facilitate the creation of accessible and affordable biologics to meet global healthcare needs.

Shenzhen TargetRx

Series A in 2020
Shenzhen TargetRx, Inc. is a pharmaceutical research and development company based in Shenzhen, China, established in 2014. As a Sino-American joint venture, it focuses on the creation of innovative anti-tumor drugs, specializing in third-generation small molecule targeted therapies for cancer patients. The company is dedicated to addressing challenges such as acquired drug resistance in cancer treatment. Under the leadership of Dr. Yihan Wang, a prominent medical expert with extensive experience in small molecule targeted therapies, Shenzhen TargetRx aims to position itself as a leading platform for targeted drug development. The company engages in the design, screening, evaluation, optimization, and research of original anti-tumor drug candidates, holding independent intellectual property rights to its innovations. With a commitment to improving cancer treatment outcomes, Shenzhen TargetRx strives to transform cancer from a leading cause of mortality into a manageable chronic condition.

Intellifusion

Series C in 2020
Shenzhen Intellifusion Technologies Co., Ltd., established in 2014, specializes in artificial intelligence and chip technology. The company focuses on developing core products, including algorithm software and AI chips, aimed at enhancing various sectors such as public safety, social governance, and the Internet of Things (IoT). Intellifusion strives to create a digital twin city through its comprehensive AI technology platform, which has been effectively implemented across numerous cities in China and Southeast Asia. With a team of international experts, the company aims to integrate AI solutions into everyday applications, significantly impacting urban management and development.

Immunocore

Series B in 2020
Immunocore Limited is a biotechnology company based in Abingdon, United Kingdom, with a focus on discovering and developing novel therapeutics for cancer, viral diseases, and autoimmune conditions. The company specializes in T cell receptor (TCR) technology, which allows it to create innovative bispecific immunotherapies. Its lead product candidate, IMCgp100, is currently undergoing clinical trials for the treatment of metastatic melanoma. Immunocore's proprietary platform enables efficient manufacturing of TCR-based drugs, addressing significant unmet medical needs. Founded in 1999 and previously known as Avidex Limited, Immunocore has expanded its operations with an additional office in Conshohocken.

Suzhou Kintor Pharmaceuticals

Series D in 2019
Suzhou Kintor Pharmaceuticals is a biopharmaceutical company established in 2009, primarily engaged in the research and development of innovative drugs targeting various cancers and androgen receptor-related diseases. Headquartered in Suzhou, China, the company focuses on addressing significant unmet medical needs in conditions such as metastatic castration-resistant prostate cancer, breast cancer, and liver cancer, which collectively represent a substantial portion of the global cancer burden. Kintor's leading drug candidates include Proxalutamide, currently undergoing clinical trials for prostate and breast cancer, and Pyrilutamide, which targets androgenetic alopecia and acne vulgaris. The company also develops several other drug candidates, including ALK-1 for liver cancer and Detorsertib, a second-generation mTOR inhibitor for metastatic solid tumors. Kintor's extensive product pipeline is built on proprietary research and development, aiming to deliver both “best-in-class” and “first-in-class” therapeutic options to patients in need.

Chengjia Apartment

Series A in 2019
Chengjia Apartment is a rental start-up that provides different product choices for apartments, hotels, and homestays. Chengjia Apartment extends the business scope to weekly rent, monthly rent, and long-term rent. The company creates a high-quality living environment with ingenuity, take care of every guest with hotel-style service, and creates a warm, comfortable, and temperature-friendly home. Chengjia Apartment is jointly established by China Living Hotel Group and IDG Capital. It has laid out nearly 100 properties in first-tier cities nationwide, with more than 10,000 houses and services. It was founded on 2015 and is headquartered in Shanghai, China.

Boston Micro Fabrication

Series A in 2019
Boston Micro Fabrication is a micro-scale 3D printing system manufacturer dedicated to the development of micro-scale 3D printing systems and functional composites. used in microfluidics, medical devices, electronics, and education.

Vapo Health

Series A in 2019
Vapo Health is a medical device company based in Kunshan City, China, focused on developing, manufacturing, and distributing products for respiratory system health. Established in 2015, the company employs advanced nano-scale atomized micro-hole technology to enhance drug delivery and particle efficiency in its offerings. Its product range includes nebulizers, spacers, thermometers, intelligent breathing trainers, and aerosol devices, as well as OEM and ODM services. Vapo Health aims to provide innovative and effective solutions to support respiratory health recovery and improve patient outcomes.

Inspur Cloud

Series B in 2019
Inspur Cloud is a prominent provider of data center and cloud computing solutions, specializing in servers, storage systems, artificial intelligence, and high-performance computing. Established in 2010 and headquartered in Jinan, China, Inspur Cloud serves a diverse clientele, including government bodies and enterprises across various sectors such as finance, education, and manufacturing. The company offers a range of products and services, including tax cloud solutions, set-top boxes, home gateways, and software outsourcing. Inspur Cloud focuses on enhancing the efficiency and transparency of its clients' operations by providing secure and effective digital solutions. As part of Inspur Group, which is recognized as the largest server manufacturer in China, Inspur Cloud plays a significant role in meeting the technological needs of its customers both domestically and internationally.

Emirates National Oil Company

Debt Financing in 2019
Emirates National Oil Company (ENOC), a wholly-owned entity of the Dubai Government, is a leading force in the economic diversification and sustainable development of the UAE Established in 1993, ENOC’s primary focus has been to develop downstream and upstream activities in the oil and gas sector. Over the years, ENOC has expanded into several high-growth business sectors to create long-term value for its stakeholders.

Momenta

Series C in 2018
Momenta is an autonomous driving startup based in Beijing that specializes in developing advanced software solutions for full autonomy in vehicles. The company leverages deep learning technologies for perception, high-definition semantic mapping, and data-driven path planning, providing multi-level autonomous driving solutions alongside big data products and services. Momenta's team includes leading experts in computer vision and deep learning, contributing to the company's innovative approach to autonomous driving. Their technology is designed to enhance driving efficiency and safety, aiming to improve the overall experience for users through artificial intelligence.

Pengyang Medical

Series A in 2018
Pengyang Medical specializes in medical monitoring hardware and information products, particularly in the realm of electrocardiogram (ECG) artificial intelligence. The company is dedicated to the research, development, and promotion of advanced ECG technology aimed at enhancing cardiovascular diagnostic services. By integrating medical resources and cutting-edge technologies, Pengyang Medical provides detailed information about patients' cardiovascular health, enabling healthcare practitioners to improve diagnostic accuracy and reduce the risk of misdiagnosis.

Suning.com

Series A in 2018
Suning.com is a prominent Chinese online shopping platform that offers a wide range of products, including clothing, snacks, electronics, and appliances. The company emphasizes a comprehensive retail experience by integrating smart retail solutions with full category operations and omni-channel services, enabling customers to shop seamlessly through physical stores, mobile devices, PCs, and TVs. Additionally, Suning.com leverages logistics and global expansion strategies to enhance its service offerings. Founded in 1990, Suning Holdings Group, which includes Suning.com, has established itself as a leading commercial enterprise in China, recognized for its significant annual revenue and diverse business interests across various sectors, including logistics, financial services, and media. Suning's commitment to improving the quality of life through technological advancements and innovative retail solutions underscores its influence in the retail landscape.

Ascentage Pharma

Series C in 2018
Ascentage Pharma Group International is a clinical-stage biotechnology company focused on developing novel small-molecule therapies for cancer, hepatitis B virus (HBV), and age-related diseases. Founded in 2009 and headquartered in Suzhou, China, the company has established a diverse pipeline of drug candidates, including HQP1351, a BCR-ABL/KIT inhibitor targeting resistant mutations, and APG-2575, an orally administered Bcl-2 selective inhibitor for hematologic malignancies. Additional candidates include APG-1252, aimed at restoring apoptosis in various solid tumors, and APG-115, which targets the MDM2-p53 interaction in solid tumors and lymphoma. Ascentage Pharma also develops APG-1387 for advanced solid tumors and chronic HBV infection, alongside other therapies for non-small-cell lung carcinoma and chronic lymphocytic leukemia. The company has entered into clinical collaborations to explore innovative treatment combinations, furthering its commitment to addressing challenging diseases in the oncology landscape.

Blocksteam

Series A in 2018
Blocksteam is a Gaming company.

LLVision

Series B in 2018
LLVISION was founded in 2014 by an elite team from Google, Lenovo, Microsoft, Intel, China Aeronautics, Nokia, Broadcom, etc.Their mission is to help the industry leaders intellectualize business processes through the first perspective innovation linked with multi-dimension connections, cognition and synergy and upgraded human-machine collaboration.

8Trip

Series C in 2018
8Trip, a China-based online travel service which connects suppliers with sellers. Currently, 8Trip covers the markets of Wuxi, Nanjing, and Anhui in China, and is planning to enter the Shanghai market next year. The company has partnerships with about 1,000 travel agencies and more than 4,000 service outlets. 8Trip was founded in December 2011 under the company name Octopus Online Tourism Development, with headquarters in Suzhou.

Oxford Nanopore Technologies

Venture Round in 2018
Oxford Nanopore Technologies is a biotechnology company specializing in nanopore-based sequencing technology for analyzing DNA, RNA, proteins, and small molecules. Its diverse product line includes the portable MinION device, the benchtop PromethION, the GridION system, and Flongle, which caters to on-demand sequencing needs. The technology enables real-time data streaming and is applicable across various fields such as human genomics, cancer research, microbiology, plant science, and environmental studies. Additionally, Oxford Nanopore's products support rapid and accessible molecular analysis, making them suitable for both laboratory and field use. The company's innovations are backed by a robust patent portfolio and are utilized in over 80 countries, addressing needs in healthcare, agriculture, and education. Founded in 2005 and headquartered in Oxford, United Kingdom, Oxford Nanopore also maintains offices in several other countries, enhancing its global reach in advancing genomic research and applications.

Innocare

Venture Round in 2018
InnoCare is a biopharmaceutical company based in China, focused on discovering, developing, and commercializing innovative treatments for cancer and autoimmune diseases. The company boasts a skilled scientific team with extensive experience in drug innovation from both the U.S. and China, supported by an accomplished Scientific Advisory Board comprised of experts from prominent universities, hospitals, and the pharmaceutical sector. InnoCare's product pipeline includes several key therapies, such as orelabrutinib, ibrutinib, zanubrutinib, and tafasitamab, targeting hematological tumors, solid tumors, and autoimmune disorders. The company is also dedicated to addressing autoimmune diseases linked to abnormal B-cell or T-cell functions, positioning itself as a leader in advancing medical treatments and tackling complex health challenges.

Chezhency.com

Series B in 2018
Chezhency.com is a B2B auto trading platform based in Shenzhen, China, founded in 2015. The company offers a comprehensive suite of services that includes automotive logistics, supply chain finance, consumer credit, and automobile insurance. By integrating these essential services, Chezhency.com aims to streamline the automotive trading process, providing businesses with efficient solutions that enhance operational effectiveness in the automotive sector.

Suzhou Kintor Pharmaceuticals

Series C in 2018
Suzhou Kintor Pharmaceuticals is a biopharmaceutical company established in 2009, primarily engaged in the research and development of innovative drugs targeting various cancers and androgen receptor-related diseases. Headquartered in Suzhou, China, the company focuses on addressing significant unmet medical needs in conditions such as metastatic castration-resistant prostate cancer, breast cancer, and liver cancer, which collectively represent a substantial portion of the global cancer burden. Kintor's leading drug candidates include Proxalutamide, currently undergoing clinical trials for prostate and breast cancer, and Pyrilutamide, which targets androgenetic alopecia and acne vulgaris. The company also develops several other drug candidates, including ALK-1 for liver cancer and Detorsertib, a second-generation mTOR inhibitor for metastatic solid tumors. Kintor's extensive product pipeline is built on proprietary research and development, aiming to deliver both “best-in-class” and “first-in-class” therapeutic options to patients in need.

ByteDance

Series D in 2017
ByteDance is a technology company that develops and operates a range of content platforms, most notably TikTok and Douyin. It aims to enhance user experiences through innovative technology, allowing individuals to connect, create, and consume content seamlessly. The company specializes in mobile applications that cater to online media, entertainment, and social networking, leveraging artificial intelligence to deliver personalized content that aligns with users' preferences. In addition to its flagship platforms, ByteDance provides tools that facilitate content creation and collaboration, reflecting its commitment to enriching lives through technology.

CooTek

Series D in 2017
CooTek is a global mobile internet company founded in 2008 and headquartered in Shanghai, with additional offices in locations such as Silicon Valley and Beijing. The company specializes in developing innovative mobile applications and artificial intelligence technology, aiming to enhance user expression and content engagement. Its flagship product, TouchPal Keyboard, offers a superior input experience for both Android and iPhone users. CooTek's portfolio includes a variety of content-rich applications across multiple categories, including online literature, mobile games, and scenario-based apps in areas such as fitness and healthcare. The company boasts a substantial user base, with its products achieving an average of 213.7 million monthly active users globally in 2018. CooTek is also committed to technology innovation, holding over 170 patents and operating a big data development center and AI lab in Silicon Valley. Additionally, the company actively contributes to academic discourse in the fields of big data and AI, with research presented at prestigious conferences.

Sooner

Angel Round in 2017
Sooner develops video technology products and services.

MEGVII

Series C in 2016
Megvii, founded in 2011, is an artificial intelligence company that specializes in intelligent solutions and data services for enterprises and developers. The company is focused on its mission to create machines capable of seeing and thinking, leveraging its deep learning system, Brain++. Megvii aims to build a comprehensive AI engine that serves as the foundational technology for various applications. It connects standardized hardware, such as sensors and personal devices, with artificial intelligence and the Internet of Things (AIoT), commercializing three main application areas: Consumer IoT, City IoT, and Supply Chain IoT. By integrating hardware and software solutions, Megvii enables clients to efficiently establish AI infrastructure tailored to their needs, positioning itself as an expert in AIoT solutions.

Shouqi Car Rental

Venture Round in 2016
Shouqi Car Rental is a car rental service and a subsidiary of Shouqi Group, a transportation company headquartered in China. It provides both business-to-business and business-to-consumer car rental solutions for institutional and individual customers. The company specializes in offering short-term and long-term rental options, allowing users to access vehicles on-demand by the hour or day. Shouqi Car Rental operates in various locations, including cities and airports within China and internationally, facilitating convenient transportation for its clientele.

Firstp2p

Series C in 2016
Firstp2p is an online lending information platform based in Beijing, China, established in 2013. The company connects individual investors with small and medium enterprises that are unable to secure traditional bank financing. In addition to facilitating these connections, Firstp2p offers a range of financial products, including car loans, mortgages, and financial leasing, aimed at supporting the funding needs of these businesses.

Firefly Games

Venture Round in 2016
Firefly Games Inc. is a mobile game developer and publisher based in Los Angeles, California, with additional offices in Shanghai. Founded in 2014, the company focuses on creating community-driven mid-core and hardcore gaming experiences for iOS and Android platforms. Firefly Games is known for titles such as Tourivia, Battle Hatchers, Fury Fables, and DreamWorks Universe of Legends. The company emphasizes the development of story-based games that are regularly updated to enhance player engagement and community interaction. Additionally, Firefly Games is involved in the fields of virtual reality and e-sports, aiming to connect gamers through evolving gameplay experiences. As of 2020, Firefly Games operates as a subsidiary of Riva Technology and Entertainment Limited and has established a strategic partnership with MSM Corporation International Limited.

Weidong Cloud Education

Venture Round in 2016
Weidong Cloud Education Group is focused on bridging the educational divide between various regions by enhancing education through technology. The company develops an internet-based educational ecosystem that offers a wide range of courses, including basic, vocational, and international education in sectors such as finance, management, medicine, and technology. Utilizing integrated "Cloud + Client" solutions, the company collaborates with leading global enterprises in software and hardware to create a comprehensive public service platform for educational resources. This initiative includes the establishment of a cloud data center and the Weidong International Education Cloud Industrial Park in Qingdao's Blue Silicon Valley, aimed at delivering high-quality educational services worldwide.

Ant Group

Series B in 2016
Ant Group Co., Ltd. is a leading provider of digital payment and financial services in China, known for its flagship product, Alipay, a widely used digital payments platform. Established in 2000 and headquartered in Hangzhou, the company offers a variety of financial solutions, including Yu'e Bao, an online cash management platform that invests users' funds in a money market fund; Huabei, a consumer credit service facilitating buy now, pay later options; and MYbank, an online bank focused on serving small businesses and entrepreneurs. Additionally, Ant Group operates Xiang Hu Bao, a mutual aid platform for health protection, and Zhima Credit, a credit assessment service for businesses. The company aims to foster digital transformation across the service industry, ensuring that consumers and small enterprises have equal access to inclusive and sustainable financial services. In July 2020, it rebranded from Ant Small and Micro Financial Services Group Co., Ltd. to Ant Group Co., Ltd.

Wellong Etown

Venture Round in 2016
Wellong Etown allows the clients to travel by car and ship all over the world, with high income and low cost for finding online smart load. Huilong installs a satellite positioning terminal for you with low fees and good service. The company finds empty trucks for your goods to be transported. It also transports online dispatching calls with high efficiency and punctuality.

Phylion Battery

Series A in 2015
Phylion Battery specializes in the development, production, and sales of lithium-ion batteries with lithium manganate as the positive electrode material. Its annual production capacity is 5GWh, which is a well-known high-tech enterprise of power lithium battery in China. Through 15 years of successful technology transformation, Phylion has provided products and services to 8 million end users and more than 45,000 electric vehicles worldwide, and provided power supply solutions for new energy vehicles around the world. Up to now, with 3GWh annual production capacity, Phylion has provided products and services for 8 million Light EV customers, 45 thousand EV customers, and various industrial projects all over the world.

XYWY.com

Series B in 2015
XYWY.com is an online platform that provides a range of medical services aimed at facilitating patient access to healthcare. The platform enables users to search for medical professionals and offers free consultations, helping patients obtain essential medical information and preliminary diagnoses. In addition to these services, XYWY.com allows clients to register for appointments and assists with drug searches and shopping guidance, consolidating various healthcare needs into a single, user-friendly interface.

Firstp2p

Series A in 2014
Firstp2p is an online lending information platform based in Beijing, China, established in 2013. The company connects individual investors with small and medium enterprises that are unable to secure traditional bank financing. In addition to facilitating these connections, Firstp2p offers a range of financial products, including car loans, mortgages, and financial leasing, aimed at supporting the funding needs of these businesses.

Taikang Bybo Dental

Series B in 2012
Taikang Bybo Medical Group is a national dental medical group with a large-scale operation. It is dedicated to providing high-quality full-lifecycle oral medical services for middle and upper-income people, pursuing the ultimate customer experience, investigating the "Caesar model" in the field of domestic oral medical services, and constructing China's largest and best high-end dental chain brand.

Galloping Horse

Private Equity Round in 2011
Galloping Horse is a cultural media group enterprise operating in advertising, TV dramas, movies, drama clubs, performing arts brokerage, and other fields.They specialize, shouldering the mission of casting products, gathering elites, and creating classics.

Green Leader

Convertible Note in 2010
Green Leader Holdings Group Ltd is a mineral exploration and development company primarily focused on investments in the mining sector, with a significant presence in Mongolia. The company operates through four main segments: Mining Operations, which involves geological surveys, exploration, and the development and sale of coking coal; Systems Integration Services and Software Solutions, offering IT products, systems integration, technology services, and software development; Cassava Starch Operations, which focuses on the cultivation and processing of cassava starch for commercial sale; and Coal Operations, which specializes in coal trading. Through these diverse segments, Green Leader aims to leverage opportunities in both the mining and technology industries.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.